Elenco completo delle pubblicazioni su riviste internazionali [PDF ...

SEIEVA – Pubblicazioni Epatite – Anni 1986-2011
1. Spada E, Tosti ME, Zuccaro O, Stroffolini T, Mele A, and Collaborating Study Group. Evaluation of the
compliance with the protocol for preventing perinatal hepatitis B infection in Italy. J Infect
2011;62(2):165-171.
2. Morisco F, Stroffolini T, Mele A, Taliani G, Smedile A, Caronna S, Tosti ME, Niro G, Levrero M, Fiorillo MT,
Amoruso DC, Ascione A, Caporaso N. Etiology of and risk factors for transient and persistent
aminotransferase elevation in a population of virus-free blood donors: A multicentre study. Dig Liver Dis
2010;42(6):441-5.
3. Mele A, Spada E, Tosti ME. Epidemiologia per la clinica e la sanità pubblica. Roma: Il Pensiero Scientifico
Editore; 2009.
4. Mariano A, Scalia Tomba G, Tosti ME, Spada E, Mele A. Estimating the incidence, prevalence and clinical
burden of hepatitis C over time in Italy. Scand J Infect Dis 2009;41:689-699.
5. Mariano A, Caserta C, Pendino GM, Vacalebre C, Surace P, Fiorillo MT, Polito I, Surace M, Alicante S,
Amante A, Foti G, Marra M, Gutamo G, Amato F, Messineo A, Mele A. Antiviral treatment for hepatitis C
virus infection: effectiveness at general population level in a highly endemic area. Dig Liver Dis
2009;41(7):509-15.
6. Tosti ME, Spada E, Romanò L, Zanetti A and Mele A on behalf of the SEIEVA collaborating group. Acute
hepatitis A in Italy: incidence, risk factors and preventive measures. J Viral Hepat 2008;15 (Suppl. 2):26–
32.
7. Mele A, Tosti ME, Mariano M, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E, and
Spada E on behalf of SEIEVA collaborating group. Acute hepatitis B 14 years after the implementation of
the universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis
2008;46(6):868-875.
8. Stroffolini T, Coppola R, Carvelli C, D’Angelo T, De Masi S, Maffei C, et al. Increasing hepatitis B
vaccination coverage among healthcare workers in Italy 10 years apart. Digest Liver Dis 2008;40(4):275-
277.
9. Tosti ME, Mariano A, Spada E, Pizzuti R, Gallo G, Ragni P, et al. Incidence of parenterally transmitted
acute viral hepatitis among healthcare workers in Italy. Infect Control Hosp Epidemiol 2007;28(5):629-
632.
10. Mele A, Mariano A, Tosti ME, Stroffolini T, Pizzuti R, Gallo G, et al. Acute Hepatitis Delta virus infection in
Italy: Incidence and risk factors after the introduction of the Universal Anti-Hepatitis B vaccination
campaign. Clinical Infection Disease 2007:44(3):17-24.
11. Gaeta GB, Stroffolini T, Smedile A, Niro G, Mele A. Hepatitis delta in Europe: vanishing or refreshing?
Hepatology 2007;46(4):1312-3.
12. Mele A, Bianco E, Mariano A, Sagliocca L et al. Expert consensus conference. The screening for hepatitis
C virus infection in adults in Italy, May 5-6, 2005. Digest Liver Dis 2006;38:445-451.
13. Marcucci F, Mele A, Spada E, Candido A, Bianco E, Pulsoni A, Chionne P, Madonna E, Cotichini R, Barbui
A, De Renzo A, Dore F, Iannitto E, Liso V, Martino B, Montanaro M, Pagano L, Musto P, Rapicetta M. High
prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. Haematologica
2006;91(4):554-7.
14. Folgori A, Spada E, Pezzanera M, Ruggeri L, Mele A, Garbuglia AR, Perrone MP, Del Porto P, Piccolella E,
Cortese R, Nicosia A, Vitelli A; Acute Hepatitis C Italian Study Group. Early impairment of hepatitis C virus
specific T cell proliferation during acute infection leads to failure of viral clearance. Gut 2006;55(7):1012-
9.

15. Sagnelli E, Stroffolini T, Almasio P, Mele A, Coppola N, Ferrigno L, Scolastico C, Onofrio M, Imparato M,
Filippini P. Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study. J
Viral Hepat 2006;13(1):67-71.
16. Zanetti AR, Mariano A, Romanò L, D’Amelio R, Chironna M, Coppola RC, et al. Long-term immunoginicity
of hepatitis B vaccination and policy for booster: an Italian multicentre study. The Lancet 2005;366:1379-
1384.
17. Rucci P, Taliani G, Cirrincione L, Alberti A, Bartolozzi D, Caporaso N, Colombo M, Coppola R, Chiaramonte
M, Craxi A, De Sio I, Floreani AR, Gaeta GB, Persico M, Secchi G, Versace I, Mele A. Validity and reliability
of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of healthrelated
quality of life. Dig Liver Dis 2005;37(11):850-60.
18. Stroffolini T, Sagnelli E, Mele A, Almasio P. Trends of aetiological factors of hepatocellular carcinoma in
Italy. Dig Liver Dis 2005;37(12):985-6.
19. Spada E, Genovese D, Tosti ME, Mariano A, Cuccuini M, Proietti L, et al. An Outbreak of hepatitis A virus
infection with a high case-fatality rate among injecting drug users. J Hepatol 2005;43:958-964.
20. Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy.
Digest Liver Dis 2005;(37):622-627.
21. D'Amelio R, Mele A, Mariano A, Romanò L, Biselli R, Lista F, Zanetti A, Stroffolini T. Hepatitis A, Italy.
Emerg Infect Dis 2005;11(7):1155-6.
22. De Masi S, Tosti ME, Mele A. Screening for hepatocellular carcinoma. Dig Liver Dis. 2005;37(4):260-8.
23. Kondili LA, Taliani G, Cerga G, Tosti ME, Babameto A, Resuli B. Correlation of alcohol consumption with
liver histological features in non-cirrhotic patients. Eur J Gastroenterol Hepatol. 2005 Feb;17(2):155-9.
24. Pendino GM, Mariano A, Surace P, Caserta CA, Fiorillo MT, Amante A, Bruno S, Mangano C, Polito I,
Amato F, Cotechini R, Stroffolini T, Mele A, and the ACE Collaborative Group. Prevalence and etiology of
altered liver tests: A population-based survey in a Mediterranean town. Hepatology 2005:41:1151-1159.
25. Sagnelli E, Stroffolini T, Mele A, Almasio P, Coppola N, Ferrigno L, Scolastico C, Onofrio M, Imparato M,
Filippini P, and operative units. The importance of HCV on the burden of chronic liver disease in Italy: a
multicenter prevalence study of 9,997 cases. J Medical Virology 2005;75:522-527.
26. Sagliocca L, Bianco E, Amoroso P, Quarto M, Richichi I, Tosti ME, Carannante N, Chironna M, Chiriacò P,
Di Bari G, Lopalco P, Resta F, Santantonio T, Tantimonaco G, Mele A. Feasibility of vaccination in
preventing secondary cases of hepatitis A virus infection. Vaccine 2005;23:910-914.
27. Fitzsimons D, Francois G, Bonanni P, Mele A, Zanetti A, Stroffolini T, Crovari P, Van Damme P. Prevention
of viral hepatitis in Italy. Vaccine 2004;22:4092-4096.
28. Mariano A, Mele A, Tosti ME, Parlato A, Gallo G, Ragni P, Zotti C, Lopalco P, Pompa MG, Graziani G, and
Stroffolini T. SEIEVA collaborating group. Role of beauty treatment in the spread of parenterally
transmitted hepatitis viruses in Italy. Journal of Medical Virology 2004;74:216-220.
29. Spada E, Sagliocca E, Sourdis J, Garbuglia AR, Poggi V, De Fusco C, Mele A. Use of the Minimum Spanning
tree model for molecular Epidemiological Investigation of a nosocomial outbreak of hepatitis C virus
infection. J Clinical Microbiology 2004;42(9):4230-6.
30. Spada E, Mele A, Berton A, Ruggeri L, Ferrigno L, Garbuglia AR, Perrone MP, Girelli G, Del Porto P,
Piccolella E, Mondelli MU, Amoroso P, Cortese R, Nicosia A, Vitelli A, Folgori A on behalf of the Acute
Hepatitis C Italian Study Group. Multispecific T cell response and negative HCV infection are early
prognostic factors of spontaneous clearance. Gut 2004;53:1673-1681.
31. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular Carcinoma in Cirrhosis: Incidence and Risk
factors. Gastroenterology 2004;127:S35-S50.
32. Bianco E, De Masi S, Mele A, Jefferson T. Effectiveness of immune globulins in preventing infectious
hepatitis and hepatitis A: a systematic review. Digest and Liver Disease 2004;36:834-842.

33. Stroffolini T, Sagnelli E, Mele A, Craxì A, Almasio P, Italian Hospitals Collaborating Group. The aetiology of
chronic hepatitis in Italy: results from a multicentre national study. Digest and Liver Disease
2004;(36):829-833.
34. Stroffolini T, Mariano A, Iantosca G. Reported risk factors are useless in detecting HCV positive subjects
in the general population. Digest Liver Dis 2004; 36: 547-550.
35. Bianco E, Marcucci F, Mele A, Musto P, Cotichini R, Sanpaolo MG, Iannitto E, De Renzo A, Martino B,
Specchia G, Pagano L, Rapicetta M, Mandelli F, Pulsoni A. Prevalence of Hepatitis C virus infection in
lymphoproliferative diseases: an Italian multicenter case-control study. Haematologica 2004;89(1):70-
76.
36. Stroffolini T, Sagnelli E, Almasio P, Ferrigno L, Craxì A, Mele A, on behalf of the Italian hospitals
collaborating groups. Characteristics of liver cirrhosis in Italy: results from a multicenter national study.
Digest Liver Dis 2004; 36: 56-60.
37. Amoroso P, Buonocore S, Lettieri G, Pierri P, Mele A. The Clinical Profile of Acute HepatitisA. Infection: is
it really so severe? [Lettera]. Hepatology 2004; 572.
38. de Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A, McIntyre N, Mele A, Paumgartner G, Pietrangelo A,
Rodés J, Rosenberg W, Valla D; EASL Jury. EASL International Consensus Conference on Hepatitis B. 13-
14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 2003;39 Suppl
1:S3-25.
39. Gaeta GB, Stornaiuolo G, Precone DF, Lobello S, Chiaramonte M, Stroffolini T, Colucci G, Rizzetto M.
Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter
Italian study. J Hepatol 2003; 39:1036-1041.
40. Stroffolini T, Bianco E, Szklo A, Bernacchia R, Bove C, Colucci M, Coppola RC, D’Argenio P, Lopalco A,
Parlato A, Ragni P, Simonetti A, and Mele A, Zotti C. Factors affecting the compliance of the antenal
hepatitis B screening programme in Italy. Vaccine 2003;21:1246-1249.
41. Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo G, Iannitto E, De Renzo A, Martino B, and et al.
Hepatitis C virus and B-cell non Hodgkin Lymphomas an Italian multicentre case-control study. Blood
2003;102(3):996-999.
42. Mele A and Jefferson T. The use of hepatitis A vaccine in Italy-evidence-based recommendations from an
expert panel (Editorial). Vaccine 2003;21:2223.
43. D’Argenio P, Adamo B, Cirrincione R, and Gallo G. The role of vaccine in controlling hepatitis A
epidemics. Vaccine 2003;(21):2246-2249.
44. Bianco E, Stroffolini T, Spada E, Szklo A, Marzolini F, Ragni P, Gallo G, Parlato A, Sangalli M, Lo palco PL,
Zotti C, Mele A, and SEIEVA collaborating group. Case fatality rate of acute viral hepatitis in Italy, 1995-
2000: an update. Digest Liver Dis 2003;(35):404-408.
45. Stroffolini T, Almasio PL, Di Stefano R, Andreone P, Di Gaetano G, Fattovich G, Gaeta GB, Morisco F,
Smedile A, Tripi S, Zignego AL, Ferraro D, Mele A, Craxi A. Anti-hepatitis A virus seroprevalence and
seroconversion in a cohort of patients with chronic viral hepatitis. Dig Liver Dis. 2002 Sep;34(9):656-9.
46. Morisco F, Rosmini F and the study group. Reliability of measurements of serum alaninetransaminase
activity and the impact on the cut-off value for the selection of blood donors. Haematologica
2002:87(5);559-560.
47. Kondili L, Chionne P, Costantino A, Villano U, La Noce C, Mele A, Giampaoli S, Rapicetta M, Pannozzo P.
Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural corse of
hepatitis C virus infection in the general population. Gut 2002;50(5):693-696.
48. Mele A, Stroffolini T, Zanetti AR. Hepatitis B in Italy: where we are ten years after the introduction of
mass vaccination. Journal of Medical Virology 2002;67:440-3.
49. Mele A. Progress in prevention and control of hepatitis B: a congress reviewing the first ten years since
the introduction of mass vaccination in Italy. J Med Virol. 2002 Jul;67(3):432.

50. De Stefano R, Stroffolini T, Ferraro D, Usticano A, Valenza LM, Montalbano L et al. Endemic hepatitis C
virus infection in a Sicilian town: further evidence for iatrogenic transmission. Journal of Medical
Virology 2002 67:339-44.
51. Cirrincione R, Taliani G, Mele A, Caporaso N. Quality of life assessment in Chronic liver disease. Hepato-
Gastroenetrology 2002;49:813-6.
52. Ciccozzi M, Tosti ME, Gallo G, Ragni P, Zotti C, Lopalco PL et al. Risk of hepatitis A infection following
travel. Journal of Viral hepatitis 2002;9:460-5.
53. Tosti ME, Solinas S, Prati D, Salvaneschi L, Manca M, Francesconi M, Ciuffrida M, Girelli M, Mele A. An
estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy.
British Journal of Haematology 2002;117:215-219.
54. Mele A, Ippolito G, Craxì A, Coppola RC, Petrosillo N, Piazza M, Puro V, Rizzetto M, Sagliocca L, Taliani G,
Zanetti A, Barni M, Bianco E, Bollero E, Cargnel A, Cattaneo M, Chiaramonte M, Conti E, D'Amelio R, De
Stefano DM, Di Giulio S, Franco E, Gallo G, Levrero M, Mannella E, Erli SM, Milazzo F, Moiraghi A, Polillo
R, Prati D, Ragni P, Sagnelli E, Scognamiglio P, Sommella L, Stroffolini T, Terrana T, Tosolini G, Vitiello E,
Zanesco L, Ziparo V, Maffei C, Moro ML, Satolli R, Traversa G. Risk management of HBsAg or anti-HCV
positive healthcare workers in hospital. Dig Liver Dis 2001;33(9):795-802.
55. Petrosillo N, Gilli P, Serraino D, Dentico P, Mele A, Ragni P, Puro V, Casalino C, Ippolito G. Prevalence of
infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney
Dis 2001;37(5):1004-1010.
56. Mele A, Tancredi F, Romanò L, Giuseppone A, Colucci M, Sangiuolo A, Lecce R, Adamo B, Tosti ME,
Taliani G, Zanetti A. Effectiveness of hepatitis B vaccination in babies born to HBsAg-positive mothers in
Italy. Journal Infectious Diseases 2001;184:905-8.
57. Mele A, Spada E, Sagliocca L, Ragni P, Tosti ME, Gallo G, Moiraghi A, Ballocchini E, Sangalli M, Lopalco PL,
Stroffolini T. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive
procedures: results from the hepatitis surveillance system in Italy. J Hepatol 2001;(35):284-289.
58. Spada E, Mele A, Ciccozzi M, Tosti ME, Bianco E, Szklo A, Ragni P, Gallo G, Ballocchini E, Sangalli M,
Lopalco PL, Moiraghi A, Stroffolini T, and SEIEVA collaborating group. Changing epidemiology of
parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Digest
Liver Dis 2001;(33):778-784.
59. Stroffolini T, Mele A, Sagliocca L. Vaccination policy against hepatitis A in Italy. Vaccine 2001;19:2404-
2406.
60. Gaeta GB, Stroffolini T, Chiaramonte M, et al. Hepatitis Delta in Italy: a vanishing disease. Hepatology
2000;32:824-7.
61. Stroffolini T, Mele A, Tosti ME, Gallo G, Ballocchini E, Ragni P, Santonastasi F, Marzolini A, Ciccozzi M,
Moiraghi A. The impact of hepatitis B mass immunization campaign on the incidence of and risk factor
for hepatitis B in Italy. J Hepatol 2000;33(6):980-5.
62. Maio G, D'argenio P, Stroffolini T, Bozza A, Sacco L, Tosti ME, Intorcia M, Fossi E, D'Alessio G, Anesti LA,
Rapicetta M, Mele A and collaborating group. Hepatitis C virus infection and alanine transaminase levels
in the general population: a survey in a southern Italian town. J Hepatol 2000;33(1):116-120.
63. Kondili LA, Taliani G, Tosti ME, De Bac C, Pasquazzi C, Mele A. Methodological issues in papers on IFN
therapy: time for reappraisal. J Viral Hepat 2000;7(3):184-95.
64. Mele A, Tosti ME, Marzolini A, Moiraghi A, Ragni P, Gallo G, Ballocchini E, Santonastasi F, Stroffolini T,
and SEIEVA collaborating group. Prevention of hepatitis C in Italy: lessons from surveillance of type
specific acute viral hepatitis. J Viral Hepatitis 2000;1(7):30-35.
65. Corona R, Stroffolini T, Giglio A, Cotichini R, Tosti ME, Prignano G, Di Carlo A, Maini A, Mele A. Lack of
evidence for increased risk of hepatitis A infection in homosexual men. Epidemiol Infect 1999;123(1):89-
93.

66. Croci L, Ciccozzi M, De Medici D, Di Pasquale S, Fiore A, Mele A and Toti L. Inactivation of hepatitis A
virus in heat-treated mussels. J Applied Microbiology 1999;87:884-888.
67. Gaeta GB, Stroffolini T, Taliani G, Ippolito FM, Giusti G, De Bac C. Surgical procedures as a major risk
factor for chronic hepatitis C virus infection in Italy: evidence from a case-control study. Int J Infect Dis
1999;3(4):207-210.
68. Mele A, Stroffolini T, Sagliocca L, Amoroso P. Hepatitis A vaccine for secondary hepatitis A infection.
Lancet 1999;354(9175):342-3.
69. Tosti ME, Traversa G, Bianco E, Mele A. Multiple sclerosis and vaccination against hepatitis B: analysis of
risk benefit profile. Ital J Gastroenterol Hepatol 1999;31:388-391.
70. Mele A, Ciccozzi M. Consumo di frutti di mare e conoscenza del rischio di epatite A. Napoli, 1997.
L'Igiene Moderna 1999;111:299-307.
71. Mele A, Stroffolini T, Tosti ME, Corona R, Santonastasi F, Gallo G, Ragni P, Ballocchini E, Bernacchia R,
Moiraghi A. Heterosexual transmission of hepatitis C in Italy. J Med Virol 1999;57:111-113.
72. Sagliocca L, Amoroso P, Stroffolini T, Adamo B, Tosti ME, Lettieri G, Buonocore S, Pierri P, Mele A.
Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A: a randomized trial. Lancet
1999;353:1136-1139.
73. Stroffolini T, Petrosillo N, Ippolito G, Lopalco A, Sagliocca L, Adamo B, Iannotti MP, Ricci Bitti P, Marzolini
A, Forastiere F, Mele A. Hepatitis B vaccination coverage among health care workers in Italy. Infect Cont
Hosp Ep 1998;19(10):789-791.
74. Caporaso N, Ascione A, Stroffolini T. Spread of hepatitis C virus infection within families. J Vir Hep
1998;5:67-72.
75. Ciccozzi M, Stroffolini T, Tosti ME, Marzolini A, Mele A. An update on post-transfusion hepatitis in Italy.
Ital. J Gastroenterol Hepatology 1998;30:665.
76. Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxi A, Chiaramonte M, Galante D, Manghisi OG,
Mazzanti R, Medaglia C, Pilleri G, Rapaccini GL, Simonetti RG, Taliani G, Tosti ME, Villa E, Gasbarrini G.
Characteristics of hepatocellular carcinoma in Italy. J Hepatol 1998;29(6):944-52.
77. Kondili L, Tosti ME, Szklo M, Costantino A, Cotichini R, Resuli B, Rapicetta M, Mele A. The relationships of
chronic hepatitis and cirrhosis to alcohol intake, hepatitis B and C, and Delta virus infection: a casecontrol
study in Albania. Epidemiol Infect 1998;121:391-395.
78. Guadagnino V, Stroffolini T, Focà ., Caroleo B, Loiacono L, Giancotti A, Menniti-Ippolito F, Piazza M.
Hepatitis C virus infection in family setting. European Journal of Epidemiology 1998;14:229-232.
79. Mele A, Tosti ME, Stroffolini T. Hepatitis associated with hepatitis A superinfection in patients with
chronic hepatitis C. N Engl J Med 1998;338(24):1771.
80. Adamo B, Stroffolini T, Sagliocca L, Simonetti A, Iadanza F, Fossi E, Tancredi F, Mele A. Ad hoc survey of
hepatitis B vaccination campaign in newborns of HBsAg positive mothers and in12-year old subjects in
southern Italy. Vaccine 1998;16(8):775-777.
81. Amoroso P, Rapicetta M, Tosti ME, Mele A, Spada E, Buonocore S, Lettieri G, Pierri P, Chionne P,
Ciccaglione AR, Sagliocca L. Correlation between virus genotype and chronic rate in acute hepatitis C.
Journal of Hepatology 1998;28:939-944.
82. Stroffolini T, Guadagnino V, Chionne P, Procopio B, Mazzuca EG, Quintieri F, Scerbo P, Giancotti A,
Nisticò S, Focà A, Tosti ME, Rapicetta M. A population based survey of hepatitis B virus infection in a
southern Italian town. Ital J Gastroenterol Hepatol. 1997 Oct;29(5):415-8.
83. Stroffolini T, Fiume A, Fatale G, Regni F, Ciccozzi M, Marzolini A, Mele A. Hepatitis C virus genotypes
among intravenous drug users in Italy. Hepatology Research 1997;9:20-27.
84. Corona R, Caprilli F, Tosti ME, Gentili G, Franco E, Zaratti L, Palamara G, Giglio A, Prignano G, Stroffolini T,
Pasquini P, Mele A. Risk factors for hepatitis C virus infection among non intravenous drug using

heterosexuals attending a sexually transmitted disease clinic in Italy. International Journal of Infectious
Diseases 1997;2(1):4-8.
85. Stroffolini T, Corona R, Giglio A, Gentili G, Caprilli F, Prignano G, Tosti ME, Pasquini P, Mele A. Risk factors
for hepatitis B virus infection among homosexual men attending a sexually transmitted disease clinic in
Italy. Microbiologica 1997;20:333-338.
86. Mele A, Stroffolini T, Palumbo F, Gallo G, Ragni P, Balocchini E, Tosti ME, Corona R, Marzolini A, Moiraghi
A and the SEIEVA Collaborating Group. Incidence of and risk factors for hepatitis A in Italy: public health
indications from a 10-year surveillance. Journal of Hepatology 1997;26:743-747.
87. Sagliocca L, Stroffolini T, Amoroso P, Manzillo G, Ferrigno L, Converti F, Palumbo F, Izzo E, Mele A. Risk
factors for acute hepatitis B: a case control study. Journal of Viral hepatitis 1997;4:63-66.
88. Stroffolini T, Cialdea L, Tosti ME, Grandolfo M, Mele A and SEIEVA collaborating group. Vaccination
campaign against hepatitis B for 12 year old subjects in Italy. Vaccine1997;15:(5)583-585.
89. Sagliocca L, Stroffolini T, Amoroso P, Manzillo G, Ferrigno L, Converti F, Palumbo F, Izzo E, Mele A. Risk
factors for acute hepatitis B: a case control study. Journal of Viral hepatitis 1997;4:63-66.
90. Stroffolini T, Ragni P, Moiraghi A, Balocchini E, Santonastasi F, Gallo G, Marzolini A, Mele A. Case fatality
rate of acute viral hepatitis in Italy. results from a ten years surveillance. Scandinavian Journal of
Infectious Diseases 1997;29:87-89.
91. Mele A, Marzolini A, Tosti ME, Ciccozzi M, Stroffolini T. SEIEVA: Sistema Epidemiologico Integrato
dell’Epatite Virale Acuta. Rapporto 1995-1996. Rapporti ISTISAN 97/36 1997.
92. Corona R, Caprilli F, Giglio A, Stroffolini T, Tosti ME, Gentili G, Prignano G, Pasquini P, Mele A. Risk factors
for hepatitis B virus infection among heterosexuals attending a sexually transmitted disease clinic in
Italy: role of genital ulcerative diseases. Journal of Medical Virology 1996;48:262-266.
93. Gentile G, Mele A, Monarca B, Vitale A, Pulsoni A, Visani G, Castelli G, Rapicetta M, Verani P, Martino P,
Mandelli F. Hepatitis B and C Viruses, Human T-Cell lymphotropic virus types I and II, and leukemias. A
case control study. Cancer Epidemiology Biomarkers Prevention 1996;5:227-230.
94. Almasio P, Mele A et al. Workshop Consensus Conference. Anti-hepatitis A virus (HAV) vaccination:
guidelines for an immunization strategy in Italy. Italian J Gastroent 1996;28:(3)181-184.
95. Stroffolini T, Marzolini A, Palumbo F, Novaco F, Moiraghi A, Balocchini E, Bernacchia R, Corona R, Mele A.
Incidence of non-A,non-B and HCV positive hepatitis cases in health care workers in Italy. Journal of
Hospital Infection 1996;33:131-137.
96. Zanetti AR, Tanzi E, Romanò L, Mele A. Epidemiology and prevention of hepatitis type C in Italy. Research
in Virology 1995;146(4)239-310.
97. Sagliocca L, Mele A, Ferrigno L, Palumbo F, Converti F, Tosti ME, Amoroso P, Manzillo G and the hepatitis
collaborating group. Case-control study on risk factors for hepatitis A: Naples 1990-1991. It J of
Gastroenterology 1995;27:181-184.
98. Mangione R, Stroffolini T, Tosti ME, Fragapani D, Mele A. Delayed third hepatitis B vaccine dose and
immune response. The Lancet 1995;345-1111-2.
99. Cialdea L, Sagliocca L, Mele A. [Epidemiology and prevention of HCV infection in dialysis centers]. Ann Ist
Super Sanità 1995;31(3):313-5.
100. D'Amelio R, Stroffolini T, Matricardi PM, Nisini R, Tosti ME, Trematerra M, Villano U, Rapicetta M, Mele
A. Low prevalence of anti-HCV antibodies among Italian Air Force Recruits. Scandinavian Journal
Infectious Diseases 1995;27:12-14.
101. Mele A, Stroffolini T, Catapano R, Palumbo F, Moiraghi A, Novaco F. Incidence of transfusion associated
B and non-A,non-B hepatitis in Italy. British Medical Journal 1995;311:846-847.

102. Mele A, Corona R, Tosti ME, Palumbo F, Moiraghi A, Novaco F, Galanti C, Bernacchia R, Ferraro P. Beauty
treatment and risk of parenterally transmitted hepatitis: Results from the Hepatitis Surveillance System
in Italy. Scand Journal Infectious Diseases 1995;27:441-44.
103. Stroffolini T, Catapano R, Marzolini A, Mele A and SEIEVA collaborating group. Hospitalization rate and
mean days of hospitalization of notified viral hepatitis cases in Italy. Ital Journal Gastroenterol
1995;27:80-82.
104. Mele A, Cialdea L, Marzolini A, Catapano R, Tosti ME, Stroffolini T. SEIEVA: Sistema Epidemiologico
Integrato dell’Epatite Virale Acuta. Rapporto annuale 1993. Rapporti ISTISAN 95/4 1995.
105. Corona R, Gandolfi C, Ferrigno L, Ciaralli F, Martelli A, Galanti C, Moiraghi A, Palumbo F, Novaco F, Stazi
MA, Mele A. Hepatitis B in children in Italy: incidence and risk factors. Eur J Epidemiol 1994;10:219-222.
106. Mele A, Catapano R, Cialdea L, Piscanc A, Mladen AS, Kresevic L. Outbreak of hepatitis A in Trieste (Italy).
Journal of Public Health Medicine 1994;16(2):242-244.
107. Mannucci PM, Santagostino E, Di Bona E, Gentili G, Ghirardini A, Gringeri A, Schiavoni M, Mele A. The
outbreak of hepatitis A in patients with hemophilia: Fact and Fancies. Vox Sanguinis 1994;67(sup.1):31-
35.
108. Cialdea L, Mele A, Stroffolini T, Novaco F, Galanti C, Catapano R, Ferraro P, Moiraghi A, Marzolini A.
Acute hepatitis B in households of chronic carriers. Vaccine 1994;12(12):1150-51.
109. Purcell RH, Mannucci PM, Gdovin S, Gringeri A, Colombo M, Mele A, Schinaia N, Ciavarella N, Emerson
SU. Virology of the hepatitis A epidemic in Italy. Vox Sang 1994;67 Suppl 4:2-7.
110. Mele A, Sagliocca L, Manzillo G, Converti F, Amoroso P, Stazi MA, Ferrigno L, Rapicetta M, Franco E,
Adamo B, Palumbo F, Sbreglia C, Panà A, Pasquini P. and SEIEVA collaborating group. Risk factors for
acute NonA,NonB hepatitis and their relationship to antibodies for hepatitis C virus: a case control study.
American Journal of Public Health 1994;84(10):1640-43.
111. Stroffolini T, Palumbo F, Galanti C, Moiraghi A, Novaco F, Corona R, Marzolini A, Mele A. Hepatitis B in
Health workers in Italy. Public Health 1994;108:433-437.
112. Mannucci PM, Gdovin S, Gringeri A, Colombo M, Mele A, Schinaia N, Ciavarella N, Emerson SU, Purcell
RH and Italian Collaborating Group. Transmission of hepatitis A to patients with hemophilia by factor VIII
concentrates treated with organic solvent and detergent to inactivate viruses. Annals of Internal
Medicine 1994;120(1):1-7.
113. Stroffolini T, Ferrigno L, Cialdea L, Catapano R, Palumbo F, Novaco F, Moiraghi A, Galanti C, Bernacchia R,
Mele A and SEIEVA collaborating group. Incidence and risk factors of acute Delta hepatitis in Italy: results
from a national surveillance system. Journal Hepatology 1994;21:1123-1126.
114. Plaitano S, Sagliocca L, Mele A, Bove C, Protano D, Adamo B, Palumbo F, Cauletti M, Franco E, Pasquini P.
Hepatitis B mass immunization of adolescents: a pilot study in a community. Eur J Epidemiol 1993;9:307-
310.
115. Mele A, Sagliocca L, Palumbo F, Novaco F, Moiraghi A, Galanti C, Bernacchia R, Pasquini P. Efficacy of
blood screening of donors for antibodies to hepatitis C virus in preventing post-transfusion nonA, nonB
hepatitis. J Public Health Med. 1993 Dec;15(4):367.
116. Mele A, Biancolilli V, D'Argenio P, Sagliocca L. Considerations on markers of hepatitis B, C and HIV as
indicators of risk behaviour in intravenous drug users. J Public Health Med 1993;15(1):112.
117. D'Amelio R, Matricardi PM, Biselli R, Stroffolini T, Mele A, Spada E, Chionne P, Rapicetta M, Ferrigno L,
Pasquini P. Changing Epidemiology of Hepatitis B in Italy: Public Health Implications. American Journal of
Epidemiology 1992;135:1012-1018.
118. Rapicetta M, Attili AF, Mele A, De Santis A, Chionne P, Cristiano K, Spada E, Giuliani E, Carli L, Goffredo F,
et al. Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population. J Med
Virol 1992;37(2):87-92.

119. Mele A, Pasquini P, Panà A. Hepatitis A in Italy: epidemiology and suggestions for control. Ital J
Gastroenterol 1991;23:341-343.
120. Corona R, Prignano G, Mele A, Gentili G, Caprilli F, Franco E, Ferrigno L, Giglio A, Titti F, Bruno C, Verani
P, Pasquini P. Heterosexual and homosexual transmission of hepatitis C virus: relation with hepatitis B
virus and human immunodeficiency virus type 1. Epidemiol Infect 1991;107-667-672.
121. Mele A, Sagliocca L, Palumbo F, Stazi MA, Rosmini F, Ferrigno L, Corona R, Osborn J, GillON, Pasquini P.
Travel associated hepatitis A: effect of place of residence and Country visited. Journal of Public Health
Medicine 1991;13:256-259.
122. Mele A, Stazi MA, Corona R, Ferrigno L, Sagliocca L, Palumbo P, Falasca P, Galanti C, Moiraghi A, Rosmini
F, Gill ON, Pasquini P and SEIEVA Collaborating Group. Decline of incidence of A, B, and nonA, nonB,
hepatitis in Italy. Results of four years surveillance (1985-1988). It J Gastroenterol 1990;22:274-280.
123. Mele A, Rezza G, Stazi MA, Gill ON, Pasquini P. Incidence of acute hepatitis B in injecting drug users as an
indicator of continuing HIV transmission--international implications. AIDS 1990;4(6):598-9.
124. Mele A. [Information system on viral hepatitis]. Epidemiol Prev 1990;12(42):6.
125. Mele A, Stazi MA, Gill ON, Pasquini P, and SEIEVA collaborating group. Prevention of hepatitis B in Italy:
lessons from surveillance of type-specific acute viral hepatitis. Epidemiol Infect 1990;104:135-141.
126. Mele A, Ferrigno L, Stazi MA, Marzolini A, Cirrincione R, Crateri S, Gill ON, Pasquini P. SEIEVA. Sistema
Epidemiologico Integrato dell'Epatite Virale Acuta. Rapporto annuale 1989 e risultati 1985-89. Rapporto
ISTISAN 90/24 1990.
127. Mele A, Rastelli MG, Gill ON, Di Bisceglie D, Rosmini F, Pardelli G, Valtriani C, Patriarchi PL. Reccurent
epidemic hepatitis A associated with consumption of raw shellfish, probably controlled through public
health measures. Am J Epidemiol 1989;130:540-546.
128. D'Argenio P, Esposito D, Mele A, Ortolani G, Adamo B, Rapicetta M, Forte P, Pisani A, Soldo L, Sarrecchia
B, Stroffolini T, Pasquini P. Decline in the exposure to hepatitis A and B infections in children in Naples,
Italy. Public Health 1989;103:385-389.
129. Stroffolini T, Pasquini P, Mele A and the Collaborating Group for vaccination against hepatitis B in Italy. A
nationwide vaccination programme in Italy against hepatitis B virus infection in infants of hepatitis B
surface antigen-carrier mothers. Vaccine 1989;7:152-154.
130. Mele A, Stroffolini T, Ferrigno L, Stazi MA, Cirrincione R, Carrieri MP, Gill ON, Pasquini P. Campagna
vaccinale anti epatite B in Italia. Rapporto annuale 1988. Rapporto ISTISAN 89/40 1989.
131. Sagliocca L, Mele A, Gill ON, Cappeta G. A village outbreak of hepatitis A: acquaintance network and in
apparent pre-school transmission compared. Eur J Epidemiol 1988;4:470-472.
132. Stroffolini T, Pasquini P, Mele A and collaborating group for vaccination against hepatitis B in Italy.
HBsAg carriers among pregnant women in Italy: result from screening during a vaccination compaign
against hepatitis B. Public Health 1988;102:329-333.
133. Mele A, Franco E, Caprilli F, Gentili G, Stazi MA, Zaratti L, Capitanio B, Crescimbeni E, Corona R, Panà A,
et al. Hepatitis B and Delta virus infection among heterosexuals, homosexuals and bisexual men. Eur J
Epidemiol 1988;4(4):488-91.
134. Mele A, Stazi AM, Ferrigno L, Cirrincione R, Mariconda E, Gill ON, Pasquini P. SEIEVA. Sistema
Epidemiologico Integrato dell'Epatite Virale Acuta. Rapporto Annuale 1987. Rapporto ISTISAN 88/13
1988.
135. Mele A, Conti S, Gill ON, Corona R, Cirrincione R, Pasquini P, e il gruppo di collaborazione SEIEVA.
Sistema Epidemiologico Integrato dell'Epatite Virale Acuta. Rapporto annuale 1986. Rapporti ISTISAN
87/1 1987.

136. Mele A, Rosmini F, Zampieri A, Gill ON and SEIEVA collaborating group. Integrated epidemiological
system for acute viral hepatitis in Italy (SEIEVA): description and preliminary results. Eur J Epidemiol
1986;4:300-304.
137. Mele A, Rosmini F, Manganella G, Gill ON ed il gruppo di collaborazione delle USL partecipanti al SEIEVA.
SEIEVA. Sistema Epidemiologico Integrato dell'Epatite Virale Acuta. Programma nazionale di sorveglianza
per l'epatite virale acuta tipo specifico. Descrizione e risultati preliminari. Rapporti ISTISAN 86/6 IT e
86/6 1986.